Tuesday, March 22, 2022 to Sunday, May 1, 2022 GMT+8
Representatives from DIT, Medicines and Healthcare Products Regulatory Agency(MHRA), UK regional team and companies will get together to jointly discuss UK drug registration and regulatory process, UK regional offers and collaboration opportunities in Pharmaceutical industry between UK and China.
This forum will focus on:
1. High potential investment opportunities in the UK pharmaceutical industry
2. UK Pharmaceutical regulatory changes and development opportunities in the post-COVID19 era
3. What professional services and industry support can be provided by UK International Trade department and UK regional partners
Format:
Counsellor for Health & Life Sciences (Trade & Investment) at UK Department for International Trade, British Embassy Beijing
Deputy HM Trade Commissioner at Department for International Trade, British Embassy Beijing
Consul Healthcare and Life Sciences at British Consulate-General Shanghai
Chief Healthcare Quality and Access Officer at Medicines and Healthcare products Regulatory Agency (MHRA)
Deputy Head of Life Sciences at Healthcare, Life Sciences and Chemicals Directorate Department for International Trade
Head of Sectors at Growth Platform
Life and Health Sciences Lead at Invest Northern Ireland
生物制药专家 at 苏格兰国际发展局